UserWiki:David Hedlund

From PsychonautWiki
(Redirected from User profile:David Hedlund)
Jump to navigation Jump to search

Hi there, I'm David Hedlund. I am from Sweden, a small country located in northern Europe, and have been editing PsychonautWiki since 4th April 2017, and I made my ten thousandth edit 15th December 2021.

"The ethereal and resplendent expanse of the cosmos, with its celestial bodies and harmonious movements, is a testament to the unity and equality of all creation under unconditional love. Its vastness and complexity inspire awe and wonder, inviting us to contemplate the mysteries of the universe and our place within it. As we gaze upon the expanse of heaven, we are reminded of the beauty and majesty of the divine, and the infinite possibilities that lie before us."

Harm reduction

Code an improved version of https://www.omnicalculator.com/health/addiction

Improvements

My special areas of interest at PsychonautWiki are

Less work:

My page creations

My page creations

Most notably:

Tutorials:

Warning panels:

Category:Substance-related lists

Subjective effects (added to list substances):

Templates:

Planned for expansion

Drafts

Personal pages

User:David Hedlund

UserWiki:David Hedlund

Did you know?

Things I consider highly relevant, that I added to articles:

Global rank statistics

Misc

DuckDuckGo bangs - https://duckduckgo.com/bangs?q=psychonautwiki

  • PsychonautWiki
  • psy
  • PsychonautWikipsychonautwiki
  • psychonaut wikipnw
  • PsychonautWikipwiki

PsychonautWiki Journal

Pages that I've created to help him

Important todo

  • Fix the notice message on Antipsychotic
    • "Antipsychotics doesn't cancel the trip. They are reducing the intensity of it, but are also extending the duration."

External links

Contact

References

  1. Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). "CBD, a precursor of THC in e-cigarettes". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMC 8076212Freely accessible Check |pmc= value (help). PMID 33903673. 
  2. Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). "Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022. 
  3. Martial, C; Cassol, H; Charland-Verville, V; Pallavicini, C; Sanz, C; Zamberlan, F; Vivot, RM; Erowid, F; Erowid, E; Laureys, S; Greyson, B; Tagliazucchi, E (March 2019). "Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports". Consciousness and cognition. 69: 52–69. doi:10.1016/j.concog.2019.01.011. PMID 30711788. 
  4. Jansen K (2001). Ketamine: Dreams and Realities. Multidisciplinary Association for Psychedelic Studies. p. 122. ISBN 978-0-9660019-3-8. 
  5. Martial, C; Cassol, H; Charland-Verville, V; Pallavicini, C; Sanz, C; Zamberlan, F; Vivot, RM; Erowid, F; Erowid, E; Laureys, S; Greyson, B; Tagliazucchi, E (March 2019). "Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports". Consciousness and cognition. 69: 52–69. doi:10.1016/j.concog.2019.01.011. PMID 30711788. 
  6. "Erowid Ketamine Vault : Ketamine and Quantum Psychiatry, by Karl Jansen". www.erowid.org. 
  7. Morales-Garcia, JA; Calleja-Conde, J; Lopez-Moreno, JA; Alonso-Gil, S; Sanz-SanCristobal, M; Riba, J; Perez-Castillo, A (28 September 2020). "N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo". Translational psychiatry. 10 (1): 331. doi:10.1038/s41398-020-01011-0. PMID 32989216. 
  8. Dos Santos, RG; Osório, FL; Crippa, JA; Riba, J; Zuardi, AW; Hallak, JE (June 2016). "Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years". Therapeutic advances in psychopharmacology. 6 (3): 193–213. doi:10.1177/2045125316638008. PMC 4910400Freely accessible. PMID 27354908.